Rubius Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2018 to Q4 2022

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Rubius Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2018 to Q4 2022.
  • Rubius Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending January 31, 2023 was 90.4M shares, a 0.35% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 90.4M +317K +0.35% Jan 31, 2023 10-K 2023-02-27
Q3 2022 90.4M +506K +0.56% Oct 31, 2022 10-Q 2022-11-09
Q2 2022 90.4M +583K +0.65% Jul 29, 2022 10-Q 2022-08-09
Q1 2022 90.2M +896K +1% Apr 29, 2022 10-Q 2022-05-10
Q4 2021 90.1M +8.9M +11% Jan 31, 2022 10-K 2022-02-25
Q3 2021 89.9M +8.94M +11.1% Oct 29, 2021 10-Q 2021-11-08
Q2 2021 89.8M +9.01M +11.2% Jul 30, 2021 10-Q 2021-08-09
Q1 2021 89.3M +8.99M +11.2% Apr 30, 2021 10-Q/A 2021-08-20
Q4 2020 81.2M Jan 29, 2021 10-K 2021-02-23
Q3 2020 80.9M +1.12M +1.41% Oct 30, 2020 10-Q/A 2020-12-04
Q2 2020 80.8M +1.12M +1.4% Jul 31, 2020 10-Q/A 2020-12-04
Q1 2020 80.3M +390K +0.49% Mar 2, 2020 10-K 2020-03-12
Q3 2019 79.8M +757K +0.96% Oct 31, 2019 10-Q 2019-11-14
Q2 2019 79.7M +609K +0.77% Jul 31, 2019 10-Q 2019-08-13
Q1 2019 79.9M Apr 30, 2019 10-Q 2019-05-15
Q3 2018 79M Oct 31, 2018 10-Q 2018-11-13
Q2 2018 79M Jul 31, 2018 10-Q 2018-08-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.